Indication
Cutaneous T-cell lymphoma
Cutaneous T-cell lymphoma is a heterogeneous group of extranodal non-Hodgkin lymphomas characterized by the malignant proliferation and infiltration of skin-homing T lymphocytes into the skin. Read more about Cutaneous T-cell lymphoma
114 drugs 92 manufacturers
Drugs that treat it
Common Cutaneous T-cell lymphoma therapies.
PREDNISONE
CYCLOPHOSPHAMIDE
PREDNISONE
CYCLOPHOSPHAMIDE
CYCLOPHOSPHAMIDE
PREDNISONE
PREDNISONE
PREDNISONE
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonCutaneous T-cell lymphoma is a heterogeneous group of extranodal non-Hodgkin lymphomas characterized by the malignant proliferation and infiltration of skin-homing T lymphocytes into the skin.
The disease primarily affects the integumentary system and typically presents in middle-aged and older adults, with a slight male predominance.
Clinically, it manifests along a continuum ranging from pruritic, erythematous patches and indurated plaques to cutaneous tumors, erythroderma, and potential dissemination to peripheral blood, lymph nodes, or visceral organs.
Mycosis fungoides and its leukemic, erythrodermic counterpart, Sézary syndrome, constitute the most common subtypes.
- nih.gov
Cutaneous T-cell lymphoma is a heterogeneous group of extranodal non-Hodgkin lymphomas characterized by the malignant proliferation and infiltration of skin-homing T lymphocytes into the skin The disease primarily affects the integumentary system and typically presents in middle-aged and older adults, with a slight male predominance Mycosis fungoides and its leukemic, erythrodermic counterpart, Sézary syndrome, constitute the most common subtypes
- nih.gov
Cutaneous T-cell lymphoma is a heterogeneous group of extranodal non-Hodgkin lymphomas characterized by the malignant proliferation and infiltration of skin-homing T lymphocytes into the skin
- cancer.gov
The disease primarily affects the integumentary system and typically presents in middle-aged and older adults, with a slight male predominance Clinically, it manifests along a continuum ranging from pruritic, erythematous patches and indurated plaques to cutaneous tumors, erythroderma, and potential dissemination to peripheral blood, lymph nodes, or visceral organs Mycosis fungoides and its leukemic, erythrodermic counterpart, Sézary syndrome, constitute the most common subtypes
- nih.gov
Clinically, it manifests along a continuum ranging from pruritic, erythematous patches and indurated plaques to cutaneous tumors, erythroderma, and potential dissemination to peripheral blood, lymph nodes, or visceral organs
Personalize your experience
Follow Cutaneous T-cell lymphoma and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.